ChromaDex
CDXC
$3.30
Share price
-5.17%
Change (1 day)
112.90%
Change (1 year)
Categories
ChromaDex (CDXC) - Cash on Hand
Cash on Hand as of December 2023 : $27.17 M
According to ChromaDex's latest financial reports the company has $27.17 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
ChromaDex - Cash on Hand chart (from 2007 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $27.17 M | 33.93% |
| 2022-12-31 | $20.28 M | -27.59% |
| 2021-12-31 | $28.01 M | 69.84% |
| 2020-12-31 | $16.49 M | -11.36% |
| 2019-12-31 | $18.61 M | -16.97% |
| 2018-12-31 | $22.41 M | -50.61% |
| 2017-12-31 | $45.38 M | 2663.53% |
| 2016-12-31 | $1.64 M | -70.4% |
| 2015-12-31 | $5.54 M | 39.98% |
| 2014-12-31 | $3.96 M | 75.33% |
| 2013-12-31 | $2.26 M | 334.87% |
| 2012-12-31 | $0.52 M | 23.76% |
| 2011-12-31 | $0.42 M | -81.13% |
| 2010-12-31 | $2.22 M | 372.33% |
| 2009-12-31 | $0.47 M | -58.12% |
| 2008-12-31 | $1.12 M | |
| 2007-11-30 | $0 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Sangamo Therapeutics
SGMO | $81 M | 198.10% | 🇺🇸 USA |
 Exelixis EXEL | $0.96 B | 3,444.90% | 🇺🇸 USA |